Elixinol Wellness Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Elixinol Wellness yıllık ortalama 54.8% oranında kazançlarını artırırken, Personal Products sektöründe kazançlar growing at 3.8% annual. Gelirler azalıyor .

Anahtar bilgiler

54.8%

Kazanç büyüme oranı

68.7%

EPS büyüme oranı

Personal Products Sektör Büyümesi	8.7%
Gelir büyüme oranı	-33.9%
Özkaynak getirisi	-92.4%
Net Marj	-59.3%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Elixinol Wellness nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:E8M Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	12	-7	9
31 Mar 24	10	-7	9
31 Dec 23	8	-8	9
30 Sep 23	8	-7	10
30 Jun 23	7	-7	10
31 Mar 23	7	-9	11
31 Dec 22	7	-11	13
30 Sep 22	7	-12	14
30 Jun 22	8	-13	16
31 Mar 22	9	-15	17
31 Dec 21	9	-17	19
30 Sep 21	11	-21	20
30 Jun 21	12	-25	22
31 Mar 21	13	-65	25
31 Dec 20	15	-105	29
30 Jun 20	21	-161	37
31 Mar 20	26	-121	38
31 Dec 19	31	-80	39
30 Jun 19	35	-10	29
31 Mar 19	34	-5	23
31 Dec 18	32	0	17

Kaliteli Kazançlar: E8M şu anda kârlı değil.

Büyüyen Kar Marjı: E8M şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: E8M kârlı değildir, ancak son 5 yılda zararlarını yılda 54.8% oranında azaltmıştır.

Büyüme Hızlandırma: E8M 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: E8M kârlı olmadığından, geçmiş yıl kazanç büyümesinin Personal Products sektörüyle ( 10.8% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: E8M hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -92.37% ) sahiptir.

Elixinol Wellness Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2023 earnings released: AU$0.016 loss per share (vs AU$0.033 loss in FY 2022)

First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.023 loss in 1H 2022)

Full year 2022 earnings released: AU$0.033 loss per share (vs AU$0.054 loss in FY 2021)

First half 2022 earnings released: AU$0.023 loss per share (vs AU$0.035 loss in 1H 2021)

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

First half 2021 earnings released: AU$0.035 loss per share (vs AU$0.60 loss in 1H 2020)

Recent updates

Elixinol Wellness Limited Announces Resignation of Tai Phan as Joint Company Secretary, Effective 25 October 2024

Elixinol Wellness Limited, Annual General Meeting, May 30, 2024

Elixinol Wellness Limited (ASX:EXL) completed the acquisition of Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF).

Full year 2023 earnings released: AU$0.016 loss per share (vs AU$0.033 loss in FY 2022)

Elixinol Wellness Limited (ASX:EXL) entered into Conditional agreement to acquire Ananda Food Pty Ltd from Ecofibre Limited (ASX:EOF) for AUD 3 million.

Elixinol Wellness Limited has filed a Follow-on Equity Offering in the amount of AUD 3.164358 million.

Less than half of directors are independent

First half 2023 earnings released: AU$0.009 loss per share (vs AU$0.023 loss in 1H 2022)

New major risk - Shareholder dilution

New minor risk - Financial data availability

Elixinol Wellness Limited has completed a Follow-on Equity Offering in the amount of AUD 1 million.

Elixinol Wellness Limited Announces Company Secretary Changes

Full year 2022 earnings released: AU$0.033 loss per share (vs AU$0.054 loss in FY 2021)

Elixinol Wellness Limited (ASX:EXL) agreed to acquire The Sustainable Nutrition Group Ltd (ASX:TSN).

First half 2022 earnings released: AU$0.023 loss per share (vs AU$0.035 loss in 1H 2021)

Elixinol Wellness Limited Announces Management Changes

Elixinol Wellness Limited, Annual General Meeting, May 26, 2022

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Elixinol Announces Launch of Two New Innovative CBD Products Focused on Supporting Sleep

Elixinol Expands Product Line With First CBD Pet Collection

First half 2021 earnings released: AU$0.035 loss per share (vs AU$0.60 loss in 1H 2020)

Elixinol Global Limited Introduces the First CBD Capsules Powered by Ginfort

Elixinol Global Limited Appoints Frank Otto as Non-Executive Director of its Board

Elixinol Global Limited Appoints Kim Bradley-Ware as Joint Company Secretary

Full year 2020 earnings released: AU$0.58 loss per share (vs AU$0.50 loss in FY 2019)

Elixinol Global Limited announced that it expects to receive AUD 8.195575 million in funding

Elixinol Launches Good Mood CBD Gummies Just in Time for 2020 Election Day

Elixinol Global Limited(ASX:EXL) dropped from S&P/ASX Emerging Companies Index

First half earnings released

Elixinol Global Limited(ASX:EXL) dropped from S&P Global BMI Index

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin